Cart
Free Shipping in Australia
Proud to be B-Corp

Developing Therapeutics for Alzheimer's Disease Summary

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges by Michael S. Wolfe (Professor of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA)

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer's disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area. Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer's disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer's disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics.

About Michael S. Wolfe (Professor of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA)

Michael S. Wolfe is the Mathias P. Mertes Professor of Medicinal Chemistry at the University of Kansas. He received his B.S. in chemistry in 1984 from the Philadelphia College of Pharmacy and Science and Ph.D. in medicinal chemistry in 1990 from the University of Kansas. After postdoctoral stints at the University of Kansas (medicinal chemistry) and the NIH (cell biology), he joined the faculty of the University of Tennessee in Memphis in 1994. In 1999, he joined the faculty at Brigham and Women's Hospital and Harvard Medical School in Boston, becoming Professor of Neurology in 2008. Prof. Wolfe's work has focused on understanding the molecular basis of Alzheimer's disease and related disorders, and identifying effective approaches for pharmacological intervention. Awards for his work include the Sato Memorial International Award in bioorganic and medicinal chemistry from the Pharmaceutical Society of Japan (2003), the MetLife Award for Biomedical Research (2008), a Zenith Fellows Award from the Alzheimer's Association (2008), and the Potamkin Prize from the American Academy of Neurology (2009).

Table of Contents

1. The Complex Pathways to Mechanism-Based Therapeutics in Alzheimer's Disease 2. The Genetic Basis of Alzheimer's Disease 3. B-Secretase Inhibition 4. Y-Secretase Inhibitors: from Chemical Probes to Drug Development 5. Therapeutic Targeting of AB42 6. Modulators of Amyloid B-Protein (AB) Self-Assembly 7. Anti-Amyloid-B Immunotherapy for Alzheimer's Disease 8. Targeting AB Receptors to Modify Alzheimer's Disease Progression 9. Blood-Brain Barrier Transport of Alzheimer's Amyloid B-Peptide 10. Alzheimer's Disease Therapeutics Targeting Apolipoprotein E 11. Microtubule Stabilization 12. Tau Phosphorylation as a Therapeutic Target in Alzheimer's Disease 13. Stimulation of Tau Degradation 14. Passive Immunotherapy for Tau Pathology 15. Inhibition of Tau Aggregation as a Basis for Treatment and Prevention of Alzheimer's Disease 16. Neuroprotective Strategies for Alzheimer's Disease Prevention and Therapy 17. Symptomatic Cognitive Enhancing Agents 18. Tackling Alzheimer's Disease by Targeting Oxidative Stress and Mitochondria 19. Preclinical and Clinical Issues in Alzheimer Drug Development 20. Molecular Imaging in Alzheimer Clinical Trials 21. Fluid Biomarkers and Diagnostics 22. Non-Pharmacologic Activity Interventions to Prevent Alzheimer's Disease 23. Prospects and Challenges for Alzheimer Therapeutics

Additional information

NPB9780128021736
9780128021736
012802173X
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges by Michael S. Wolfe (Professor of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA)
New
Hardback
Elsevier Science Publishing Co Inc
2016-06-16
676
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Developing Therapeutics for Alzheimer's Disease